News

Eric Shinseki, secretary of Veterans Affairs, is planing to lease 2.4 acres to a private-sector medical facility. The lease is in exchange for construction of building for the

Osteologix has reported that the Japan Patent Office (JPO) has issued a decision to grant a patent for application number 2006-504379: Treating Cartilage/Bone Conditions with Water-Soluble Strontium Salts.

NovaDel Pharma has received a payment of approximately $150,000 from Velcera, relating to its License and Development Agreement with Velcera dated June 22, 2004. Reportedly, the agreement provides

Procter & Gamble and Warner Chilcott have sealed an agreement for the sale of P&G’s global pharmaceuticals business to Warner Chilcott for a cash payment of $3.1 billion.

GxP Consulting has announced expansion plans in the US and UK markets. Led by Mark Stevens, managing director at GxP Consulting, the company has launched a strategy to

Seattle Genetics has completed enrollment in its pivotal clinical trial of brentuximab vedotin (SGN-35), for relapsed and refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted

Santhera and Biovail have signed a license agreement for Santhera’s JP-1730/fipamezole. Biovail has acquired the US and Canadian rights to develop and commercialise the drug for the treatment

Foamix has received US Patent No. 7575739 pertaining to its foam technology. The patent covers foam compositions, suitable for the treatment of heat and chemical burns, wounds, bacterial,

Resolvyx has reported positive data from a phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic